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Letters to the Editorantifungal) and the duration of therapy
(lifelong antibiotic therapy?).
In our opinion, the open questions
remain: (1) Which antibiotic therapy
should be performed in patients with
ABF treated with thoracic endovascu-
lar aneurysm repair? (2) How long
should antibiotic therapy be continued?
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Bozzani and colleagues1 state that
surgical correction of an aortobron-
chial fistula, particularly open cor-
rection of a thoracic aneurysm,
carries a fairly high postoperative
incidence of stent-graft infection.
To the contrary, minimal infection
rates were observed after endovascu-
lar stent placement. The authors
question whether antibiotic therapy
should be administrated after this
minimally invasive operational
procedure.1,2 There is scarce litera-
ture on immunologic consequences
after stent implantation in humans.
According to immunologic data
obtained from patients undergoing
heart operations with cardiopulmo-
nary support and abdominal surgery,
any operation performed in humans
induces a state of immune suppression
in vivo. Therefore, patients undergoing
heart surgery (cardiopulmonary support)512 The Journal of Thoracic and Cshould receive aggressive 5-day antibi-
otic treatment in accordance with the in-
sight of an induced ‘‘systemic immune
suppression’’ after heart surgery.3,4 In
regard to the ongoing discussion of anti-
biotic treatment after endovascular stent
implantation, the following approach
seems to be feasible. Studies have to
be initiated to investigate the immuno-
logic consequence of open and endovas-
cular stent implantation in humans (eg,
abdominal aorta aneurysm repair,
open, closed), and ‘‘yes,’’ antibiotic
treatment should be applied for 4 to 5
days after endovascular stent placement
to potentially ‘‘prohibit’’ pain from in-
fection (local, systemic) in patients.
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TECHNIQUE TO CARBON
DIOXIDE DE-AIRING IN OPEN
CARDIAC OPERATIONS?
To the Editor:
In a recent study Al-Rashidi and as-
sociates1 concluded that ‘‘bilateral .ardiovascular Surgery c February 2010pulmonary collapse and successive
filling of the lungs with . concomi-
tant increase in mechanical ventilation
during de-airing of the left side of the
heart significantly reduces the number
of systemic MES [microembolic sig-
nals]. and. air emboli.’’
Inasmuch as the study’s limitations
were not mentioned, we would like
to discuss a few:
1. Inasmuch as the patients were alter-
nately allotted to control and study
groups, the principle of randomiza-
tion was ignored. Moreover, the
principle of unbiased assessment
was also compromised inasmuch
as the single surgeon, who actively
followed the degree of de-airing via
transesophageal echocardiography
(TEE) during the surgical de-airing
maneuvers before the end of car-
diopulmonary bypass (CPB), thus
participated in the evaluation of
the technique, which he himself
had proposed.
2. The authors enumerate 9 exclusion
criteria, including accidental open-
ing of the pleural cavity and
chronic obstructive lung disease,
although all operations were per-
formed by one highly experienced
surgeon. Consequently, the gener-
alizability of the results cannot but
be very limited.
3. According to the Methods section,
TEE and transcranial Doppler
(TCD) measurements were only
performed after CPB. However, in
the Results section, the authors
make comparisons with the number
of MES before the end of CBP.
Moreover, ‘‘The aortic root was
de-aired’’ before release of the
crossclamp only in the study group.
4. The possible risks of a left ventricu-
lar vent inserted through the apex of
the heart (eg, bleeding and arrhyth-
mias), a prerequisite of the tech-
nique, have not been mentioned.
5. In contrast to common practice as
well as the study group, the con-
trol group patients had their
lungs ventilated continuously during
Letters to the Editorcrossclamping and then fully al-
ready after release of the cross-
clamp. This may have negatively
influenced the number of detected
MES and TEE-detected air emboli
in the control group.
6. The authors claim that ‘‘their re-
sults are similar, if not better, to
those described with carbon diox-
ide insufflation’’ and refer to a study
by us.2 We find this comparison in-
appropriate. Continuous carbon di-
oxide insufflaton of the open
cardiothoracic cavity during open
cardiac surgery with an effective
device creates a local atmosphere
of 100% carbon dioxide,3,4
whereby only carbon dioxide and
not air can enter the heart and the
vessels directly. Thus, any gaseous
microemboli detected with TEE or
TCD during and after CPB must
contain carbon dioxide and not
air, unless air is introduced indi-
rectly via cannulas. As expected,
we found that the TEE-detected mi-
croemboli were fewer and disap-
peared much quicker in our
treatment group receiving carbon
dioxide.2 In contrast, the new surgi-
cal de-airing technique1 did not
eliminate the risk of air embolism,
inasmuch as air emboli were still
present in the left side of the heart
and MES containing air still oc-
curred. Furthermore, our study2
randomized patients, all 6 surgeons
were blinded to TEE findings, the
apex of the heart was not cannu-
lated, and we did not have exclu-
sion criteria.
In conclusion, if proven able to re-
duce air embolization in a correctly
performed randomized trial, the de-
scribed technique1 may be a comple-
ment to de-airing with carbon dioxide
only, if air has been introduced into
the left heart and the great vessel
directly, by use of an inappropriate
carbon dioxide insufflation technique,
or indirectly, through cannulas.
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We thank Peter Svenarud and his
colleagues for their valuable com-
ments and questions about our article
in the Journal.1 We will try to answer
their queries in the order of their ap-
pearance in their letter to the Editor.
In our prospective controlled study,
the de-airing was performed in both
groups under intraoperative transeso-
phageal echocardiographic (TEE) con-
trol. When air bubbles ceased to
appear in the left side of the heart, the
de-airing was stopped and the de-air-
ing time noted. During this period, mi-
croembolic signals (MES) were also
recorded by transcranial echo-Doppler
(TCED) on line in both groups. The
surgeon obviously could not influence
these data in favor of one or the other
group. Subsequent analysis of the
data showed that, in addition to the sig-
nificantly longer de-airing time (P<
.001), the number of MES recorded
were also significantly higher in the
control group (P < .002). We also
found a good correlation existing be-
tween the TEE and TCED measured
air emboli in both groups (during the
first 10 minutes after weaning patientsof Thoracic and Cardiovascular Surgefrom cardiopulmonary bypass), so
a bias in favor of the technique pro-
posed by us is unlikely.
The clinical study under discussion
is the second in a series of studies un-
der way. Patient inclusion and exclu-
sion criteria were purposely kept
strict to allow us to draw definite con-
clusions from the small number of pa-
tients included in the study. It is,
however, too early to predict the real
limitations to the de-airing technique
proposed by us.
Our study has focused on two end
points: (1) ‘‘the de-airing time’’ based
on the cessation of air emboli on intra-
operative TEE and (2) the ‘‘residual
microemboli’’ during the first 10 min-
utes after termination of cardiopul-
monary bypass as assessed by
intraoperative TEE and TCED. In ad-
dition, the number of MES as recorded
by online TCED during the ‘‘de-airing
time’’ itself were also analyzed. Dur-
ing the de-airing period itself, assess-
ment of the magnitude of the air
emboli on TEE is not only difficult
but also fraught with numerous errors.
Moreover, a major amount of these
emboli are being evacuated by the
left ventricular vent. That is why
TCED data alone were considered for
assessing the magnitude of systemic
air emboli in both groups during the
de-airing period itself.
In the control group, the aortic root
was de-aired by filling it passively
with blood from the left ventricle be-
fore final closure of the aortotomy.
Thereafter, the left side of the heart
was manually de-aired through the
left ventricular apical vent under con-
tinued passive filling of the lungs
with blood and full ventilation of lungs
with 100% oxygen. The aortic clamp
was released first thereafter. In the
study group, on the other hand, the
aortic root was de-aired by filling it
passively with blood by release of the
aortic clamp under low systemic blood
pressure over a short period of time
before final closure of the aortotomy.
The aortic clamp was releasedry c Volume 139, Number 2 513
